80
Participants
Start Date
December 16, 2019
Primary Completion Date
November 18, 2021
Study Completion Date
July 20, 2022
URO-902
intradetrusor injection
Placebo
intradetrusor injection
Accumed Research Associates - ClinEdge - PPDS, Garden City
Great Lakes Physician PC / Western New York Urology Associates, Cheektowaga
Institute For Female Pelvic Medicine, Allentown
Chesapeake Urology Associates, Hanover
Urology of Virginia, Virginia Beach
Urology Specialists of The Carolinas, Huntersville
Atrium Healthcare, Charlotte
Precision Clinical Research LLC, Sunrise
Coastal Clinical Research Inc, Mobile
Beaumont Hospital, Royal Oak
Iowa Clinic, West Des Moines
Urological Associates of Southern Arizona, Tucson
University of Southern California - Norris Hospital, Los Angeles
Tri Valley Urology Medical Group, Murrieta
Orange County Urology Associates, Laguna Hills
Stanford University School of Medicine, Palo Alto
Washington Urology & Urogynecology Associates, Kirkland
Bay State Clinical Trials, Watertown
Premier Urology Group, LLC, Edison
Urology Center of Englewood, Englewood
Urovant Sciences GmbH
INDUSTRY